FDA Inspection 763002 — Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated — FEI 1000513211

The FDA completed an inspection of Vertex Pharmaceuticals Incorporated on Jan 13, 2012 in Boston, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 13, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Boston, MA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.